Catching HBV early can make a world of difference. Medical professionals typically use blood tests that check for signs of the virus in the body, such as HBV antigens or antibodies. They also ...

Durham-based Precision BioSciences Inc. has received investigational new drug (IND) clearance from the U.S. Food and Drug Administration (FDA) for PBGENE-HBV, an in vivo gene editing program designed ...

PBGENE-HBV specifically targets a highly conserved sequence within the hepatitis B viral genome. It utilises the ARCUS gene editing platform, delivering a nuclease-encoding mRNA to the liver ...